Man Group’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,499
| Closed | -$450K | – | 1966 |
|
|
2024
Q1 | $450K | Buy |
+1,499
| New | +$450K | ﹤0.01% | 1695 |
|
|
2022
Q4 | – | Sell |
-176
| Closed | -$10K | – | 2057 |
|
|
2022
Q3 | $10K | Buy |
+176
| New | +$10K | ﹤0.01% | 1939 |
|
|
2021
Q2 | – | Sell |
-279
| Closed | -$84K | – | 1924 |
|
|
2021
Q1 | $84K | Sell |
279
-292
| -51% | -$87.9K | ﹤0.01% | 1803 |
|
|
2020
Q4 | $215K | Buy |
+571
| New | +$215K | ﹤0.01% | 1723 |
|
|
2019
Q3 | – | Sell |
-4,955
| Closed | -$5.91M | – | 1822 |
|
|
2019
Q2 | $5.91M | Sell |
4,955
-510
| -9% | -$608K | 0.02% | 874 |
|
|
2019
Q1 | $6.81M | Sell |
5,465
-489
| -8% | -$609K | 0.03% | 746 |
|
|
2018
Q4 | $5.64M | Buy |
5,954
+1,834
| +45% | +$1.74M | 0.03% | 710 |
|
|
2018
Q3 | $5.93M | Buy |
4,120
+3,553
| +627% | +$5.12M | 0.02% | 884 |
|
|
2018
Q2 | $914K | Buy |
+567
| New | +$914K | ﹤0.01% | 1615 |
|